Get started
Author

Chiho Nakashima

Observed names: C. Nakashima, CHIHO NAKASHIMA, Chiho nakashima, NAKASHIMA, Chiho, Nakashima, Chiho
Institution: Saga University
ORCID: 0000-0001-7918-7282
Observed ORCID: 0000-0001-7918-7282
OpenAlex ID: A5062825946
Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer
2019 · Kazutoshi Komiya, Tomomi Nakamura, et al. · Thoracic Cancer · 59
PDF
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
2016 · Kazutoshi Komiya, Tomomi Nakamura, et al. · OncoTargets and Therapy · 53
PDF
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
2018 · Akemi Sato, Chiho Nakashima, et al. · Oncotarget · 38
PDF
Mechanisms of acquired resistance to afatinib clarified with liquid biopsy
2018 · Tomomi Nakamura, Chiho Nakashima, et al. · PLoS ONE · 33
PDF
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
2018 · Chiho Nakashima, Akemi Sato, et al. · Oncotarget · 30
PDF
Dysautonomia associated with immune checkpoint inhibitors
2023 · Toshiki Tezuka, Shinichi Okuzumi, et al. · Journal of Neurology · 23
Origin of circulating free DNA in patients with lung cancer
2020 · Tomonori Abe, Chiho Nakashima, et al. · PLoS ONE · 16
PDF
Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy
2018 · KAZUTOSHI KOMIYA, CHIHO NAKASHIMA, et al. · Anticancer Research · 16
PDF
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
2021 · Akiko Matsumoto, Chiho Nakashima, et al. · BMC Cancer · 12
PDF
The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment
2021 · Naoko Sueoka‐Aragane, Chiho Nakashima, et al. · Cancer Medicine · 12
PDF
A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease
2021 · Hironori Sadamatsu, Koichiro Takahashi, et al. · Journal of Clinical Medicine · 12
PDF
A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung
2020 · Hironori Sadamatsu, Koichiro Takahashi, et al. · Journal of Infection and Chemotherapy · 12
Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer
2017 · Naomi Kobayashi-Watanabe, Akemi Sato, et al. · Lung Cancer · 11
Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer
2017 · Tsuyoshi Miyahara, Naoko Sueoka-Aragane, et al. · Medical Oncology · 10
Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report
2017 · Haruki Hirakawa, Chiho Nakashima, et al. · Journal of Medical Case Reports · 10
PDF
A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy
2018 · Haruki Hirakawa, Kazutoshi Komiya, et al. · Annals of Translational Medicine · 9
PDF
Absence of copy number gain ofEGFR: A possible predictive marker of long‐term response to afatinib
2022 · Tomomi Nakamura, Akemi Sato, et al. · Cancer Science · 8
PDF
Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer
2021 · Natsuko Komiya, Koichiro Takahashi, et al. · Case Reports in Oncology · 8
Case report: Efficacy of immune checkpoint inhibitors for high tumour mutational burden malignant phyllodes tumours of the breast as revealed by comprehensive genomic profiling
2025 · Hiroo Katsuya, Haruhiko Sano, et al. · Frontiers in Immunology · 7
Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath
2022 · Yuki Kurihara, Hiroki Tashiro, et al. · Thoracic Cancer · 7
PDF
Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea
2020 · RINTARO SOGAWA, CHIHO NAKASHIMA, et al. · In Vivo · 7
PDF
Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic
2025 · Sakiko Kimura, Sakiko Kimura, et al. · BMC Immunology · 2
PDF
Toxocariasis presenting with peripheral eosinophilia and eosinophilic pleural effusion: A case report
2026 · Mizuki Nanri, Hiroki Tashiro, et al. · Journal of Infection and Chemotherapy · 1
Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes
2025 · Kazuhiro Ko, Mayu Fukuda, et al. · International Journal of Clinical Oncology · 1
PDF
Examining the Formalin Fixation Method for Maintaining High RNA Quality in Surgical Lung Specimens
2025 · Takashi Teishikata, Manabu Itoh, et al. · Thoracic Cancer · 1
PDF
Works count: 58
Citation count: 402
H-index: 12
I10-index: 15
Year
Topic
Type